共 48 条
SURVIVAL OF MOTOR NEURON PROTEIN OVER-EXPRESSION PREVENTS CALPAIN-MEDIATED CLEAVAGE AND ACTIVATION OF PROCASPASE-3 IN DIFFERENTIATED HUMAN SH-SY5Y CELLS
被引:10
作者:
Anderton, R. S.
[1
,2
]
Meloni, B. P.
[1
,2
]
Mastaglia, F. L.
[1
,2
]
Greene, W. K.
[3
]
Boulos, S.
[1
,2
]
机构:
[1] QEII Med Ctr, Australian Neuromuscular Res Inst, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia
[3] Murdoch Univ, Sch Vet & Biomed Sci, Murdoch, WA 6150, Australia
来源:
关键词:
SMN;
anti-apoptotic;
adenoviral;
SMA;
caspase-3;
NEUROTROPHIC FACTOR;
RETINOIC ACID;
CYTOCHROME-C;
GENE-PRODUCT;
SMN PROTEIN;
APOPTOSIS;
MODEL;
OVEREXPRESSION;
HSP27;
EXCITOTOXICITY;
D O I:
10.1016/j.neuroscience.2011.02.032
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Spinal muscular atrophy (SMA), a neurodegenerative disorder primarily affecting motor neurons, is the most common genetic cause of infant death. This incurable disease is caused by the absence of a functional SMN1 gene and a reduction in full length survival of motor neuron (SMN) protein. In this study, a neuroprotective function of SMN was investigated in differentiated human SH-SY5Y cells using an adenoviral vector to over-express SMN protein. The pro-survival capacity of SMN was assessed in an Akt/PI3-kinase inhibition (LY294002) model, as well as an oxidative stress (hydrogen peroxide) and excitotoxic (glutamate) model. SMN over-expression in SH-SY5Y cells protected against Akt/phosphatidylinositol 3-kinase (PI3-kinase) inhibition, but not oxidative stress, nor against excitotoxicity in rat cortical neurons. Western analysis of cell homogenates from SH-SY5Y cultures over-expressing SMN harvested pre- and post-Akt/PI3-kinase inhibition indicated that SMN protein inhibited caspase-3 activation via blockade of calpain-mediated procaspase-3 cleavage. This study has revealed a novel anti-apoptotic function for the SMN protein in differentiated SH-SY5Y cells. Finally, the cell death model described herein will allow the assessment of future therapeutic agents or strategies aimed at increasing SMN protein levels. (C) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:226 / 233
页数:8
相关论文